Skin Tumors and Reactions to Cancer Therapies (STARC)
Pediatric skin tumors are rare but serious, and even standard cancer treatments can result in both short- and long-term skin-related effects. Understanding how these tumors develop and evolve, as well as identifying and managing treatment-related skin reactions, is essential to ensuring better outcomes and quality of life for young patients.
The STARC Focused Study Group is a multidisciplinary team dedicated to improving our understanding of primary skin tumors in children, building long term data on precursors to skin malignancy, and responding to cutaneous complications from cancer therapies. Through ongoing collaboration, data sharing, and focused research, the group aims to identify gaps in care, define unmet needs, and advance strategies that reduce harm and support children and families navigating cancer treatment.
Learn more about the work of PeDRA’s STARC FSG through a PeDRA Pearls interview with Dr. Christina Boull and Dr. Rebecca Levy. Click here to listen.
The STARC Breakout Session at PeDRA 2025.
Chairs
The STARC Focused Study Group is Chaired by Christina Boull, MD of the University of Minnesota, and Vice-Chaired by Rebecca Levy, MD of the University of Toronto.
University of Minnesota
University of Toronto
Links and Resources
Questions or looking to get involved?
Email us to get connected to the STARC group or to learn more.